Advertisement
Advertisement
U.S. markets open in 4 hours 19 minutes
Advertisement
Advertisement
Advertisement
Advertisement

DarioHealth Corp. (DRIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.31+0.10 (+1.92%)
At close: 04:00PM EDT
5.48 +0.17 (+3.20%)
After hours: 07:53PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inverted Hammer

Inverted Hammer

Previous Close5.21
Open5.30
Bid0.00 x 900
Ask0.00 x 1000
Day's Range5.08 - 5.33
52 Week Range4.11 - 23.36
Volume1,963,813
Avg. Volume289,730
Market Cap116.749M
Beta (5Y Monthly)1.35
PE Ratio (TTM)N/A
EPS (TTM)-4.47
Earnings DateAug 15, 2022 - Aug 19, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.34
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for DRIO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • DarioHealth Corp.
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
  • PR Newswire

    DarioHealth Announces New Contract with a National Employer

    DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced a new contract to deliver its digital behavioral health solution for a leading provider of integrated technology solutions for financial professionals. The new account is expected to launch in the third quarter of 2022.

  • PR Newswire

    Solera Health Adds DarioHealth to Its Cardiometabolic Network to Offer Hypertension Management Solutions

    Solera Health, the premier platform for connecting people seamlessly and easily to proven, personalized health solutions, announces its partnership with DarioHealth, a leading digital therapeutics company revolutionizing how people with chronic conditions manage their health through a user-centric platform. Together, Solera and DarioHealth are offering a turnkey, world class solution for treating hypertension, requiring just one contract and one technical integration to make this compelling new

  • PR Newswire

    DarioHealth Secures $50 Million Dollar Non-Dilutive Credit Facility with OrbiMed

    DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it closed a senior secured term loan facility of up to $50 million with OrbiMed, a leading investor in the healthcare industry, providing non-dilutive capital to fund the continued development of its platform and the acceleration of its adoption in the multi-billion dollar global chronic disease management market.

Advertisement
Advertisement